Beyond the normal semaglutide fatigue that many users experience, protein deficiency creates its own distinct exhaustion
Well also perform labs regularly to keep an eye on your internal health, such as monitoring your glucose and cholesterol levels
STEP 1 Trial Wilding et al., New England Journal of Medicine (2021) Wilding and colleagues conducted the Semaglutide Treatment Effect in People with Obesity (STEP 1) trial: a 68-week, double-blind, randomized, placebo-controlled phase 3 trial conducted at 129 sites across 16 countries
The FDA, EMA, or any regulatory authority for human therapeutic use, diagnosis, treatment, or supplementation does not approve it
Each patients response to the medication is unique, and regular follow-up visits are necessary to ensure the medication is working effectively and that any potential side effects are addressed